p24 |
|
|
The genome and proteins of HIV have been the subject of extensive research since the discovery of the virus in 1983. It is a well known fact that no two HIV genomes are the same, not even from the same person, causing some to speculate that HIV is a "quasispecies" of a virus.[1] Structure Figure 1. Diagram of HIV HIV is different in structure from previously described retroviruses. It is around 120 nm in diameter (120 billionths of a meter; around 60 times smaller than a red blood ...
Wikipedia - [full article]
p24 Clinical Trials
- A Study to Test the Safety of Three Experimental HIV Vaccines
ClinicalTrials.gov Identifier: NCT00000946 - Active, not recruiting
HIV Infections; HIV Seronegativity
- A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults
ClinicalTrials.gov Identifier: NCT00002204 - Completed
HIV Infections; HIV Seronegativity
- A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects
ClinicalTrials.gov Identifier: NCT00001053 - Completed
HIV Infections
- A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults
ClinicalTrials.gov Identifier: NCT00412477 - Completed
HIV Infections
- A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC
ClinicalTrials.gov Identifier: NCT00000735 - Completed
HIV Infections

Not Signed In -


